Bertoldi M, Dominici P, Moore P S, Maras B, Voltattorni C B
Istituto di Chimica Biologica, Facoltà di Medicina e Chirurgia, Università degli Studi di Verona, Strada Le Grazie, 8, 37134 Verona, Italy.
Biochemistry. 1998 May 5;37(18):6552-61. doi: 10.1021/bi9718898.
Dopa decarboxylase (DDC) catalyzes the cleavage of alpha-methylDopa into 3,4-dihydroxyphenylacetone and ammonia, via the intermediate alpha-methyldopamine, which does not accumulate during catalysis. The ketone has been identified by high-performance liquid chromatography and mass spectroscopic analysis, and ammonia by means of glutamate dehydrogenase. Molecular oxygen is consumed during the reaction in a 1:2 molar ratio with respect to the products. The kcat and Km of this reaction were determined to be 5.68 min-1 and 45 microM, respectively. When the reaction is carried out under anaerobic conditions, alpha-methyldopamine is formed in a time-dependent manner and neither ammonia nor ketone is produced to a significant extent. The reaction is accompanied by a time- and concentration-dependent inactivation of the enzyme with kinact of 0. 012 min-1 and Ki of 39.3 microM. Free 3,4-dihydroxyphenylacetone binds to the active site of DDC and inactivates the enzyme in a time- and concentration-dependent manner with a kinact/Ki value similar to that of alpha-methylDopa. d-Dopa, a competitive inhibitor of DDC, protects the enzyme against inactivation. Taken together, these findings indicate the active site directed nature of the interaction of DDC with 3,4-dihydroxyphenylacetone and provide evidence that the ketone generated by the reaction of DDC with alpha-methylDopa dissociates from the active site before it inactivates the enzyme. Inactivation of the enzyme by ketone followed by NaB3H4 reduction and chymotryptic digestion revealed that the lysine residue which binds pyridoxal 5'-phosphate (PLP) in the native enzyme is the site of covalent modification. Together with the characterization of the adduct released from the inactivated DDC, these data suggest that the enzyme is inactivated by trapping the coenzyme in a ternary adduct with ketone and the active site lysine. As recently reported for serotonin (5-HT) [Bertoldi, M., Moore, P. S., Maras, B., Dominici, P., and Borri Voltattorni, C. (1996) J. Biol. Chem. 271, 23954-23959], the conversion of dopamine (DA) into 3,4-dihydroxyphenylacetaldehyde and ammonia catalyzed by DDC is accompanied by irreversible loss of decarboxylase activity. However, the comparison between the absorbance, fluorescence, and CD features of DDC after 5-HT- or 3, 4-dihydroxyphenylacetone-induced inactivation shows that a different covalent adduct is formed between either of these two molecules and DDC-bound PLP.
多巴脱羧酶(DDC)催化α-甲基多巴通过中间体α-甲基多巴胺裂解为3,4-二羟基苯丙酮和氨,α-甲基多巴胺在催化过程中不会积累。已通过高效液相色谱和质谱分析鉴定出该酮,并用谷氨酸脱氢酶鉴定出氨。反应过程中消耗的分子氧与产物的摩尔比为1:2。该反应的催化常数(kcat)和米氏常数(Km)分别测定为5.68 min⁻¹和45 μM。当反应在厌氧条件下进行时,α-甲基多巴胺以时间依赖性方式形成,并且在很大程度上不会产生氨和酮。该反应伴随着酶的时间和浓度依赖性失活,失活常数(kinact)为0.012 min⁻¹,抑制常数(Ki)为39.3 μM。游离的3,4-二羟基苯丙酮与DDC的活性位点结合,并以时间和浓度依赖性方式使酶失活,其kinact/Ki值与α-甲基多巴相似。d-多巴是DDC的竞争性抑制剂,可保护酶不被失活。综上所述,这些发现表明DDC与3,4-二羟基苯丙酮相互作用的活性位点导向性质,并提供证据表明DDC与α-甲基多巴反应产生的酮在使酶失活之前从活性位点解离。酮使酶失活后,经硼氢化钠还原和胰凝乳蛋白酶消化表明,天然酶中结合磷酸吡哆醛(PLP)的赖氨酸残基是共价修饰的位点。连同从失活的DDC释放的加合物的表征,这些数据表明该酶通过将辅酶捕获在与酮和活性位点赖氨酸的三元加合物中而失活。正如最近关于血清素(5-HT)的报道[Bertoldi, M., Moore, P. S., Maras, B., Dominici, P., and Borri Voltattorni, C. (1996) J. Biol. Chem. 271, 23954 - 23959],DDC催化多巴胺(DA)转化为3,4-二羟基苯乙醛和氨伴随着脱羧酶活性的不可逆丧失。然而,5-HT或3,4-二羟基苯丙酮诱导失活后DDC的吸光度、荧光和圆二色性特征的比较表明,这两种分子中的任何一种与DDC结合的PLP之间形成了不同的共价加合物。